Recursion Pharma
在场
是其中之一......
Recursion Pharma 是一家在股票代码 RXRX (US) 下上市的公司。
涉及Recursion Pharma的并购和融资。
- Recursion Pharma 刚刚宣布为 50 筹款数百万美元。 (公布2023七月17号).
- Recursion Pharma has announced the acquisition of Cyclica (公布2023五月12号).
高管
查看带有其 62 名主要高管的组织结构图
Recursion Pharma 搜索最多的简介
- Chris Gibson, Chief Executive Officer and Director
- Martin Chavez, Chairman of the Board
- Zavain Dar, Board Member
高管在Recursion Pharma变化
- Najat Khan已作为Director, Chief R&D Officer and Chief Commercial Officer加入公司 (新闻发布的2024四月17号).
创建提醒
跟踪 Recursion Pharma 的高管变动
药店
Recursion Pharma 拥有 1,867 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Recursion Pharma 的最新新闻稿
- Recursion Announces Plans to Open New Office in London | Recursion Pharmaceuticals, Inc.
- Recursion to Host Public L(earnings) Call on February 27 | Recursion Pharmaceuticals, Inc.
- Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology | Recursion Pharmaceuticals, Inc.
- Press Releases | Recursion Pharmaceuticals, Inc.
- Press Releases | Recursion Pharmaceuticals, Inc.
- Recursion Partners with NVIDIA in Groundbreaking Collaboration
- Recursion Releases MolRec, a Compound Intelligence Tool for Drug Discovery, Alongside the Largest of Its Kind Open-Source Dataset During First R&D Day
- Recursion to Participate in Upcoming Investor Conferences
- Press
- Recursion to Participate in Upcoming Investor Conference
- View more press releases Close
通过电子邮件
